-
1
-
2
-
3
-
4
-
5
-
6
Enhancing dose selection in phase I cancer trials: Extending the Bayesian Logistic Regression Model with non-DLT adverse events integration
出版 2025主題: “...Bayesian Logistic Regression model...”
-
7
-
8
-
9
-
10